Literature DB >> 6693950

Dural arteriovenous malformations of the spine. Clinical features and surgical results in 55 cases.

L Symon, H Kuyama, B Kendall.   

Abstract

The clinical and angiographic findings of 55 patients with a spinal dural arteriovenous malformation (AVM) are reviewed, and the results of surgery assessed. The symptoms of dural AVM are usually gradual in onset, and hemorrhage from this type of AVM is less common than in true spinal cord angiomas. Other clinical features and the myelographic findings are similar to those of spinal cord angiomas. On angiography, the nidus of dural AVM's usually projected lateral to the spinal cord. Clipping of communicating vessels between the AVM and the coronal plexus was carried out in 50 patients, and decompressive laminectomy only in five cases. Surgery led to improvement of disturbed gait or arrest of a previously progressive course in 85% of those managed by clipping communicating vessels. The pathophysiology and surgical treatment of dural AVM's are discussed.

Entities:  

Mesh:

Year:  1984        PMID: 6693950     DOI: 10.3171/jns.1984.60.2.0238

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  42 in total

1.  Secondary clinical deterioration after successful embolization of a spinal dural arteriovenous fistula: a plea for prophylactic anticoagulation.

Authors:  J Knopman; W Zink; A Patsalides; H A Riina; Y P Gobin
Journal:  Interv Neuroradiol       Date:  2010-07-19       Impact factor: 1.610

Review 2.  Arteriovenous fistulas at the cervicomedullary junction presenting with subarachnoid hemorrhage: six case reports with special reference to the angiographic pattern of venous drainage.

Authors:  Yutaka Kai; Jun-ichiro Hamada; Motohiro Morioka; Shigetoshi Yano; Takamasa Mizuno; Jun-ichi Kuratsu
Journal:  AJNR Am J Neuroradiol       Date:  2005-09       Impact factor: 3.825

3.  Double spinal dural arteriovenous fistulas.

Authors:  A El-Serwi; A Maubon; J Vidal; R Chapot
Journal:  AJNR Am J Neuroradiol       Date:  2006-02       Impact factor: 3.825

4.  N-butyl 2-cyanoacrylate embolization of spinal dural arteriovenous fistulae: CT evaluation, technical features, and outcome prognosis in 26 cases.

Authors:  Remy Guillevin; J N Vallee; E Cormier; D Lo; D Dormont; J Chiras
Journal:  AJNR Am J Neuroradiol       Date:  2005-04       Impact factor: 3.825

5.  Single center experience with treatment of spinal dural arteriovenous fistulas.

Authors:  Neriman Özkan; Ilonka Kreitschmann-Andermahr; Sophia Luise Goerike; Karsten Henning Wrede; Bernadette Kleist; Klaus-Peter Stein; Oliver Gembruch; Ibrahim Erol Sandalcioglu; Isabel Wanke; Ulrich Sure
Journal:  Neurosurg Rev       Date:  2015-07-17       Impact factor: 3.042

6.  Spinal dural arteriovenous malformations with perimedullary drainage. Indications and results of surgery in 30 cases.

Authors:  K L Mourier; F Gelbert; A Rey; E Assouline; B George; D Reizine; J J Merland; J Cophignon
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

7.  Sacral meningeal arteriovenous fistula fed by branches of the hypogastric arteries and drained through medullary veins.

Authors:  J L Burguet; J L Dietemann; A Wackenheim; P Kehr; F Buchheit
Journal:  Neuroradiology       Date:  1985       Impact factor: 2.804

8.  Clinical Characteristics and Treatment Outcomes of Spinal Arteriovenous Malformations.

Authors:  Ji Eun Park; Hae-Won Koo; Hairi Liu; Seung Chul Jung; Danbi Park; Dae Chul Suh
Journal:  Clin Neuroradiol       Date:  2016-09-13       Impact factor: 3.649

9.  Superselective angiography of a spinal dural arteriovenous fistula having a common segmental origin with the artery of Adamkiewicz.

Authors:  S Aggarwal; R Willinsky; W Montanera; K Terbrugge; M C Wallace
Journal:  Neuroradiology       Date:  1992       Impact factor: 2.804

10.  Spinal arteriovenous shunts presenting as intracranial subarachnoid haemorrhage.

Authors:  J van Beijnum; D C G Straver; G J E Rinkel; C J M Klijn
Journal:  J Neurol       Date:  2007-04-02       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.